Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin with Neoadjuvant Chemotherapy in Breast Cancer
NCT07067307Phase 2Not yet recruiting
- Sponsor
- Mansoura University
- Start
- Jul 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melatonin in breast cancer, sponsored by Mansoura University. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
melatonin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07067307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07067307.